{"record_id":"pl:presentation:87203","market_asked":null,"heading":"Related records in other markets","related_records_in_other_markets":[{"record_id":"be:presentation:cti:195002-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"195002-01","pack_level_published":true,"name":"NovoNorm 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"1998-08-17","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"Sp5qRafRx8tyFzGtDerqexqM1mJVH9w7EauelnxZ2sH3zmPzstRVX0vQez70lFv3tshlYQhjAp99aLRGA_39vw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/195002-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:195011-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"195011-01","pack_level_published":true,"name":"NovoNorm 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"1998-08-17","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"yNWG21nFXggPjkc-lFCn976qeimHtk1QdfaVTzPHyRkMUgMU-tMS2TZO235XIz-5s1IRD4P22y22hRvq7-6Wcw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/195011-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:195027-01","market":"BE","level":"presentation","gtin":"05712249109042","national_pack_code":null,"pack_level_published":true,"name":"NovoNorm 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":true,"lifecycle":"current","period_from":"2024-01-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ACiQel3zGtEO3ygczTym2WKyz7SNe08EJMygbAHp7oO5vELBfH1eo_kzNieINZdTAUXCrcSalB4Wc804GVtf8Q","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/05712249109042","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:224743-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"224743-01","pack_level_published":true,"name":"Prandin 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2001-01-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"FvatSJ43_XzifDubgjXA554UPvdOmflMOFdq2VCEAVtVH-NRdjYBEx5x5yDmTWNVOLMxaeVC2E3HBhgZPFrAGA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/224743-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:224752-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"224752-01","pack_level_published":true,"name":"Prandin 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2001-01-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"VaK_c_F5N1e1Ca2eoFaik9y4FDJcfGUA_l3EX2mTKhk5WasVLM4hgC7uBN5vVXHFAAMyuxPMCJeGFGKB8rWnyA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/224752-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:224761-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"224761-01","pack_level_published":true,"name":"Prandin 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2001-01-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"upyytsI4vXNnV0n5MWmviz1WZM21dG1Tc7M8liIXZhLEU2W3v3HHBJcH0VxwnR8WJ5zODmeVUDGbps3yTcznfA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/224761-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:284392-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"284392-01","pack_level_published":true,"name":"Prandin 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2006-05-22","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"rLFOT0cKQ5_SjHNP-nbeelFFyJXmqH1HyaDqn2Ood_g7lcINkE0-xVmENdUC0E5V1zd6z466SM0_Z7Io8c87QQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/284392-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:284435-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"284435-01","pack_level_published":true,"name":"NovoNorm 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2006-05-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"gaNrJQuE3OSouyZZzPZbTQgg2FUGb49O578ZK6D1x-oUfIymkQIxmA07BlOx0muiged1QSxHwUfsW4QiDWedzA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/284435-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346464-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346464-01","pack_level_published":true,"name":"Repaglinide Teva 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"72mB32dYBE0gjBGjAdHPqcIpWSxeEyFJGuDnOgZB_uf_pRcThEijjYk2_e7f0-0WsuLmJiYZFu_4d2YKVkp5yA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346464-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346473-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346473-01","pack_level_published":true,"name":"Repaglinide Teva 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"TTUa6Bm3qxMvUk--y2bF1SkJ-Pf_T2NXZEYVxrOjenoj2xCjHs4veJS5YoLiktOlieO7C0ApWlC6tkPI1MBy0w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346473-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346482-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346482-01","pack_level_published":true,"name":"Repaglinide Teva 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"w_k1xjk1geaLKnd53zKDhmGIT7pJcM0XmB2b_-FHqBY0xKPjCK4PMvVLqexZtHetCl1BqIY3UHLGnwQ_QzHiWg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346482-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346491-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346491-01","pack_level_published":true,"name":"Repaglinide Teva 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"DzzG12eFLOxhheMzyld8NHMGKrVWL66kk22JqJaQdU3sZlD6o1zRi8vasSez7FWSgkfjhxFAHzy_qk9SSVkWVQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346491-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346507-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346507-01","pack_level_published":true,"name":"Repaglinide Teva 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["360"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"fi4MOM8fE2ETtPS25GDXDEMrtpfQ-7KiK794KyYXw_FNaCd2io55bqB5-V9i5ad-HZKrdOdUC3Pex4nNJtQEfQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346507-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355661-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355661-01","pack_level_published":true,"name":"Repaglinide EG 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["15"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"yoAYIP9IgDkvQXy4uKgHnVs75qixZvupryG3o574urrxEH5Al03mXly2PrJe4qG1aSQtH8ZMul5UqPopdkQ3Ow","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355661-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355661-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355661-02","pack_level_published":true,"name":"Repaglinide EG 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"PlNGcSH_e0prZfnfMaXkj6mCNlIwdDykDyHenjMMd0JQEmdKK4jL5mSbFbwEt0k5xpG3t_XFe_km0mZ6jU08bg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355661-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355661-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355661-03","pack_level_published":true,"name":"Repaglinide EG 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"j-vy0gsvrhtrlR7eCH0AD6CtYuDLT1CYAVQWk4GWP8HTIWNyQDB0ZMZeVZ38AxVw_-Zw3oQYDsam8beVsT16Mw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355661-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355661-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2720951","pack_level_published":true,"name":"Repaglinide EG 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2019-03-16","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"zZD650KB_1lhtG9khZ36GsBnfBj0UOh1y1C2fxaejVXyIg3JP8KyWaXujj2ep39VAqYM_ihnbpUtOIRanbdjZA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2720951","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355661-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355661-05","pack_level_published":true,"name":"Repaglinide EG 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["180"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"rLyFY5GdT4KTdZF8qCeXw5ROrV1LMmbYjK-Q1JGJ89_n_rE0FAj6H51OdY--uR2MOd8ULAVlt0XJNidv48Tgrg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355661-05","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355661-06","market":"BE","level":"presentation","gtin":"05400581005725","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide EG 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2025-10-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"W6Uvrh6pck6BUAMzMbO8ESDLRjluSaprXsyqfOmgVAzKmGoPwq70bNGZkFPbVH3i5w5V4GDI83IvB25HfpP3AA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/05400581005725","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356666-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356666-01","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ficqetN7rB_iLRFl8K2fTwpHllgkbzSiO6phnRq7B7jcO63k4zhFePq9DOizjNZo6GCULZkCYtJaOGVjmEqQYQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356666-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356666-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356666-02","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["60"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"CSBA33cjCNSmPktpTDM1UCTpN4Gw7-SqTllTa36znNNMA5Pczzys_Q3uXXFEGNNrnYwpQdEQ46b7mw2cudyfXw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356666-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356666-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356666-03","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"1ucHDcwzzLwj8tUZRRVPMV4BJvjXX5x0ar6bRzK88wnfkhlSkcQBoAK7OXr-KKKOiTYwWOPAhhI550eRwVQMoQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356666-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356666-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2753242","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2020-03-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"66ba6YgiqbkOHXj_sXtkvgoFUkmR56gqofFSw3jonOKNA71MGH2fkmgF7mtMZ60OEAz0rqME9ijoi811VAanAQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2753242","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356666-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2953115","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2020-03-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"v7T4kk2DhVIhITp6cAS3WlsLPLKwSlToQ-6SLmnrMm61a9IB5xJIpFdcNQfxavqsqysfmySS-0ex0sml2pukPw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2953115","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356675-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356675-01","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"QiRGcvh7mzyttBmsql1-mNMKs1zKFF6gQ4oMcDnRAuyCGY-cITw1wH46VkBM04rbyBwVqINeY4-6W9n-KCIFEw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356675-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356675-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356675-02","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["60"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"XDJOslsO87kEIeUfqz-CTuyy25Lx9gkUIN78Yk_brtgTYUOuMB6XqkFsbHpn8sEdzUd746Rc0fyTJnOcb-vOEQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356675-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356675-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356675-03","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"IrAa46Bieb-PgUgi-pdsYEyD85_SJNsaUqWvqj6YAWEcaQOraWNq2MJv3NDlK0R0Ulx62kMEUhigPmaBaFDuQQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356675-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356675-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356675-04","pack_level_published":true,"name":"Repaglinide Sandoz 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["250"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"d07mDnbbWFSql4SoltlSpxJrefcLyd2bM3xtgSyTTELMliQzqj-ijjKpgSWGkd6gQT9NtwUAR8Ft99si42AOqg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356675-04","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358032-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358032-01","pack_level_published":true,"name":"Repaglinide Krka 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"bMRcK4lCqkZ8ExUkbOL0lrlkwJi-3Mth8QG1vZWR1Max5J7YuCIswIS-IBNAnae1mvmrJe6he4w7k1ov8AXGYg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358032-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358041-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358041-01","pack_level_published":true,"name":"Repaglinide Krka 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["60"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"CfELEJfzkmIbnxorShqVk_OGnbIrExT_l6R6BX8F56P5MT5GBFvhPxP3tJCZzPxBzqA0rsxudGHFsPbnvD7yyA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358041-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358057-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358057-01","pack_level_published":true,"name":"Repaglinide Krka 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"LDmpJhTMLYdURJzAreoHNMaYEnfkjjcdpKXMsDaNfW37hGcsqE9SiD-IDhjUjrzbMIVLmsOvr3BMu_Pz0RDbwg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358057-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358066-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358066-01","pack_level_published":true,"name":"Repaglinide Krka 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"zIsLk65w77Gks10C2Z1g-k8HK6eoPu7odqmoowWVUx2PLhJYFX3swrR3qNDF7RgZwjWIZuD41uZpWFEkrYdecw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358066-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358145-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358145-01","pack_level_published":true,"name":"Repaglinide Krka 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"18ZOIMC3x99MgvRJowtky7vj2ZW7q2UNymmznEc9RvOYHxTU2j464Tki7DgeX2ynGNxdCBrPPXmYuU4OsrJU5w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358145-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358154-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358154-01","pack_level_published":true,"name":"Repaglinide Krka 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["360"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"guvwYSbrV8_dxAa2GAusXnKRisvKYzb9ThWpeTxAAK1fBLzTwsNcZAaBTKwytsQuzBP_-_KRTTXaGeouOhHb3A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358154-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358285-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358285-01","pack_level_published":true,"name":"Enyglid 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"SNE64rEs_eZApFB4qCpgWdKXvvwFfU_9iwvKltvau7RkljW1S-ubmxslPYwBd50NKOn5mcYjs5CPip5vkAty_g","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358285-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358294-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358294-01","pack_level_published":true,"name":"Enyglid 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["60"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"2wu4SODymgUWPCB6wSE2-NUeaGKZ4X9OniXCPhDg5a_YLK0VTdZ-E0zHiz1n0jxCvZXqfxcwvk9t7tgw8qV--A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358294-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358303-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358303-01","pack_level_published":true,"name":"Enyglid 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"zvzx01NYS3R8qAe5zFshDY8GTbr5qnqUhjo-yAseaOk2_3jcVYhIcmmuZoC_hy6o7CRYaM2fXilwrG2lvKXTfw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358303-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358312-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358312-01","pack_level_published":true,"name":"Enyglid 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"F36Thu_CI44Pd06j-WPDA2a2_dGdfYK8n4r95rRt4oB0iZW9r5KrmsIH6wJAGfGwp385Cc6RyJyaKGllwGyCvg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358312-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358321-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358321-01","pack_level_published":true,"name":"Enyglid 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"eDd_MiTLNnugF0nAly0ah7uXfLGZEcvffVuRtiCNETe4zwV3De5JhC7ufV_LG4IVm_HrQrJp_r-xUK9WIaywwQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358321-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358337-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358337-01","pack_level_published":true,"name":"Enyglid 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["360"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"BXbjK83F1l-tOftAo1lPaiQhxrk8xfUxDMATm4dSDdZm9GtlajTAIp5VKGoGDFy9uOi8Pg2a1oi78de09tVSqg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358337-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378576-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378576-01","pack_level_published":true,"name":"Repaglinide Mylan 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"iLW29Av-3QuDvOISIr0Aq3VsyA64Ry5to5TGrRZEIhxHnzHekQ3xTecd_yCijgbVMAx0fnSGj3tQBsEB3n1INA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378576-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378576-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378576-02","pack_level_published":true,"name":"Repaglinide Mylan 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"xVsjDCauc2L8iAc-Z73wyMPlHhvzDwMwY47qSxtzdh0W0rSmAJpAEUiNOFlfZ1DIHaXagiLaJj91skOccxamDQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378576-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378576-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2793867","pack_level_published":true,"name":"Repaglinide Mylan 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"Jh1uKWeEeEVdZ0UHj7UfGZUVz9ZFkvF0zae_8twSeB2E_hIbbaqyMIfNtMjJmDoyQ-te5lQVXR-qJFwy2VC9gw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2793867","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378576-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2804292","pack_level_published":true,"name":"Repaglinide Mylan 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["200"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"a9XnMdUyf9s2-N91x4---_UxtCaP32RxqRtpPCaaSvEeWO8hffpSvBLm0ZrbtjeoxRFd7BSQ7gHNxo_MrWbETg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2804292","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378576-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378576-05","pack_level_published":true,"name":"Repaglinide Mylan 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"kFE_R6LTo8eLoXzi2DAQ4phcLHD8OL90XHdN6TQyea0h7ROAqQD4nfOftrxGtZ_6EMtF2OAMuzppwFBn1bzqnA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378576-05","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378585-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378585-01","pack_level_published":true,"name":"Repaglinide Mylan 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["100"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"tqezvTL3SRa-_H2rzquQLlBqmuX-OysDVn9T15Gy7AbeFRtTIiEDjFy8qm2KUd2oW_oNT_Iw2D7Tl3DY6ndk0g","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378585-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:386617-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"386617-01","pack_level_published":true,"name":"Enyglid 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["180"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2010-11-03","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"5OSDXHKn4sTw3peor2fig5j-dHOKKCyo-paCrvOHXVrKiiZs3BDwDAqHNXER-ZsjWUhfdHtAaVfDRWO0B0P-lQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/386617-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412754-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412754-01","pack_level_published":true,"name":"Repaglinide Accord 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"8Z8bqneHUNqdwQPKy14SwEWWFvpW0opxHcMUGrgo6Dte5cqoCXSABIhaN58FXgRBrQSqkNMR4dBt_pwZ_GH54A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412754-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412763-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412763-01","pack_level_published":true,"name":"Repaglinide Accord 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"f9lLQ-QsCbAPWOooazmB8EHp8GRdVKhyfw3Cz6ecUTv9Kvol06LewmR0Ub2aYm3SLuG3t7DFNZ6Y6-3B8QWpbg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412763-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412772-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412772-01","pack_level_published":true,"name":"Repaglinide Accord 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"PWsXM-HgoHLJxx0bJRKluO36R0hVAu5-5LMSd1uJap9h_JQEFtjGGPsObYMoj1LKio1J_v-VWlOuFqOLO7RNxg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412772-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412781-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412781-01","pack_level_published":true,"name":"Repaglinide Accord 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"slc1IduILwRmcy9BVzAtF46ooY7eoIN0mzR-gdCwaFiE3RqztWA-md8bLQ5x4XKHkEFFiTms8wZX6KVDYJG40w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412781-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412797-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412797-01","pack_level_published":true,"name":"Repaglinide Accord 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["100"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"hJizz0idIvRZToYvCdArNHl6_N_GcOqVNckjKmnRjNoCgt52pSQI_uvbMWpwqgcM1cBvK_l8L-lv4kX6XtYStw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412797-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422466-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422466-01","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"hi4WlFq-sCCsfX52Mf8w0aA3s10_pA4-G6o4l2_kELcfvHdyAwKKDIbxc-mgsMumiG5C5u94dUe3nK1uc1IQMA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422466-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422466-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422466-02","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"7t3QHOmkVFlZ1CMU3N5IsVinaHVLOPlhSNGwZer-Je08Jr3iEDbvoJhgfa1ZNcbZy6PLivX3FIcsnztcX45NRQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422466-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422466-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422466-03","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"DV0-gcoAPpJ11_4pZT5kAj6mAjPTsm_i-qQcpcT_QR3-7sWMT5nBsFvoa37NDe5ZE0tg2Je0WwlzlbnLvJpTZA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422466-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422466-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422466-04","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["180"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"c3niIEvTd16rTXBiQf0We-5DaymNi4qWWWzDCUBgxsQ5b35uW0QldL77vspAnkYsN0jGN5Jx9yCkW74LvOZtuQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422466-04","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422466-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422466-05","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["200"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"xL7fJ5jjXDiUz1jhga8eVkHxwc4Tu7-QsgvDsMgLuQq1mpugfmia7T9tXRIRH8WncdkGw8-I7VjZlefD6aBtXg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422466-05","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422466-06","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422466-06","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"jTpnxNDy4-flV8ekA--rGEs62MkyMR4LaeAzwUsrfMPQo8qey-jy1ybHnFZAUCuTbkMGCIRJvFVZEUXJJvE7vQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422466-06","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422475-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422475-01","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"IQpRxAVqWvqfsafp1H5rTy5yIHwN307aaU42QZUwMgOcFSOfWfvXzSyM83GPBPyUWurWqGHUWgITTuTnMW8wPA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422475-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422475-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422475-02","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["200"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"mPj6W9m-QS1xL5hqa2oaAP_0oMsxVnixmwUfvN1bvltZzU2D50d1WcSk33eZht6aK2odg5b835JzCP-pbsOXpg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422475-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422475-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422475-03","pack_level_published":true,"name":"Repaglinide Mylan Pharma 0,5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"mP7PXiEK0MI5ARboptPEoeMdALX-49SUtcdhUihYGXfppT6saVY5Um9Tqql-eH8jJXB8RYWs5GOzBzBjc7LDYA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422475-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:494942-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"494942-01","pack_level_published":true,"name":"Repaglinide Accord 0.5 mg","substance":["Repaglinide"],"strength":["0.5000 mg"],"form":["Tablet"],"pack":["180"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"d6K8ZjppY6nHKH2kafvPOLmqMT3YCdFSvdk57kBtwyew-T3DJCu17S0vzPu5Jm1hEO-8mFV-6AaXxwB_QEeszw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/494942-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20100119/001","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20100119/001","pack_level_published":true,"name":"Neoglinid","substance":["Repaglinide"],"strength":["0.5 mg tablets"],"form":["tablets"],"pack":["90"],"holder":"Нео Балканика ЕООД","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"f6Vnrm7G205xs1GYt2Hzs3ukzDignRnxY0b2Kf6DyTMmqD1Dtridz9YYLiaLKtcHPdVftewPU3RkPPMFyaEvJA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20100119/001","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"ch:presentation:61234-016","market":"CH","level":"presentation","gtin":"07680612340164","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide Rivopharm, compresse","substance":["repaglinidum"],"strength":["Repaglinide Rivopharm 0.5 mg, compresse","0.5 MG"],"form":["TAB"],"pack":["90"],"holder":"Rivopharm SA","status":{"state":"current","value":{"first_authorisation":"2011-05-24","term":"zugelassen","valid_until":"9999-12-31"}},"source_authority":"Swissmedic","read_at":"2026-11-15T01:25:13Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"9C6f9lEByLP359-BpIc_Ojfk40xIm0-Sl3eo4rTuNIqnliS6S2aND6Qy8k4Mqy8taRKjTSUhms9EFd_VnSPnDw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/ch/07680612340164","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:038294","market":"DK","level":"presentation","gtin":"07046260382947","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide \"Accord\"","substance":["Repaglinid"],"strength":["0,5 mg"],"form":["tabletter"],"pack":["90 stk. (blister)"],"holder":"Accord Healthcare","status":{"state":"current","value":{"left_list_on":"2026-08-31","lifecycle":"history","on_price_list":false}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"eIKwP4Dzs1iFGf5_mrFVmzDNnDnawBW5PbQ1EM1kl5l9TykYHxWrTFeXH-1s8PRo3gza6r9vGZ9nSSCIA8VtUA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046260382947","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:053776","market":"DK","level":"presentation","gtin":"07046260537767","national_pack_code":null,"pack_level_published":true,"name":"NovoNorm","substance":["Repaglinid"],"strength":["0,5 mg"],"form":["tabletter"],"pack":["90 stk. (blister) (2care4)"],"holder":"2care4","status":{"state":"current","value":{"left_list_on":"2024-01-22","lifecycle":"history","on_price_list":false}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"KYxHZGW2LvLMn1VlY5DVModvtHRHTp8j_ZcFTDUrDCZ-CYmt8KzuOaAhd_eNfNGNHoYqerzZZZ1LG0YZfxY33w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046260537767","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:150402","market":"DK","level":"presentation","gtin":"07046261504027","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide \"Accord\"","substance":["Repaglinid"],"strength":["0,5 mg"],"form":["tabletter"],"pack":["30 stk. (blister)"],"holder":"Accord Healthcare","status":{"state":"current","value":{"left_list_on":"2022-08-08","lifecycle":"history","on_price_list":false}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"F2v1cw3GTdnrKKRBzsJjFGByCB9q1vad2Dbm6M72N-iJ7XqfgJP-McwbbZ_3YAvjULddoq4SPtRvWFRKrKv6qw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046261504027","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:164800","market":"DK","level":"presentation","gtin":"07046261648004","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide \"Krka\"","substance":["Repaglinid"],"strength":["0,5 mg"],"form":["tabletter"],"pack":["90 stk. (blister)"],"holder":"Krka AB","status":{"state":"current","value":{"left_list_on":null,"lifecycle":"current","on_price_list":true}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ZCwdlFN2eadpt9UwabPCTEhAJKYG-6X-XIS0sJGZpjjH6MXRV9yU1iHxYyHqM7duH2FLBQLHyVW2_c0sioEeew","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046261648004","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:517714","market":"DK","level":"presentation","gtin":"07046265177142","national_pack_code":null,"pack_level_published":true,"name":"NovoNorm","substance":["Repaglinid"],"strength":["0,5 mg"],"form":["tabletter"],"pack":["90 stk. (blister)"],"holder":"Novo","status":{"state":"current","value":{"left_list_on":"2025-05-26","lifecycle":"history","on_price_list":false}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"dynyF8gSF8vPj7iCZpuaDSWojnlVK_BzDK1ABR5L2evaT-U-Zf17QACGBtuc_5p47irfrd0f_epnwsDSov4FmQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046265177142","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:650706","market":"ES","level":"presentation","gtin":"08470006507063","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA SANDOZ 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"SANDOZ FARMACEUTICA S.A.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-05-24","pack_status":"Anulado","pack_status_date":"2021-05-24"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"3xASSrEOR4C44F9CFF9krPmxe9WCAjhwM3DVhPQbm5R28Ge9YieFqIXMpNn79oLr-O_mZ4Bv6_akyNRJQKV8Kw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006507063","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:651142","market":"ES","level":"presentation","gtin":"08470006511428","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA CINFA 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS CINFA S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2011-10-24","pack_status":"Suspenso","pack_status_date":"2024-04-02"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"kLhspgyyp2GT25cof64Li9nSXmjWouc678gxiq_bgO_LeDCNaZaCLY-q99TUszPj6oDS5Z_l9hV-0sr7XIRqXA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006511428","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:652553","market":"ES","level":"presentation","gtin":"08470006525531","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA AUROVITAS SPAIN 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"AUROVITAS SPAIN, S.A.U.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2022-01-25","pack_status":"Anulado","pack_status_date":"2022-01-25"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"z34L3hkeGzKm3BpGPszDVYluyE5nxbpRdJGtwbOKVNPf49MzTHmfq1u4GWz7ej0y6AmO8Jb0DSyv0-dC6SNbtA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006525531","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:672339","market":"ES","level":"presentation","gtin":"08435232343298","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA NORMON 0,5 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS NORMON S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-05-12","pack_status":"Autorizado","pack_status_date":"2010-08-31"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"flJ1DiL8kBGK0-Jua8cbFTF2npeItoqgyV_HeVu4Juba6IeC5DMIxCwGOj-8i6V31O20Hw9lRAEFvIeMwjUn4A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08435232343298","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:673011","market":"ES","level":"presentation","gtin":"08470006730119","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA RATIOPHARM 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"RATIOPHARM ESPANA S.A.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2019-07-19","pack_status":"Anulado","pack_status_date":"2019-07-19"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"nuERSumZguxsTHK_wvKY6g_UW_wpL4xDOG2vFbsBnp_3Aypvh6uV7pViCDeL8-Pg-tKGusGXyUA5sINks8lsug","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006730119","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:673900","market":"ES","level":"presentation","gtin":"08470006739006","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA STADA 0,5 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIO STADA S.L.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-06-20","pack_status":"Autorizado","pack_status_date":"2011-03-25"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"iv4U7cyT611FiEyNum5pWRNTLpV7a17-a8ZQsmKXnXpSJBGJ1CEQywfyCb-3PSzoly3tTZIBWclY66c5KSzWmw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006739006","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:675149","market":"ES","level":"presentation","gtin":"08470006751497","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA APOTEX 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"APOTEX EUROPE B.V.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-01-21","pack_status":"Anulado","pack_status_date":"2021-01-21"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"QKPTYSCSSqbUvj_oJn51zjaDvKzXng_PRErURJEGxWEwZlvCe3YVKCS4tnzQl5zS46ZCogUBTe4wNSzYpUDvAA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006751497","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:676235","market":"ES","level":"presentation","gtin":"08470006762356","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA VIATRIS 0,50 MG COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"VIATRIS LIMITED","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-09-21","pack_status":"Autorizado","pack_status_date":"2011-04-14"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"OD2fkdiAhwLRMUMgm2mSZZa7ny1I7Ax0ozY0b2RbbSndyJC9NHy2lj1mMB1LXXbtRfhVWARf9PJYrnKG_td9Hg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006762356","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:677663","market":"ES","level":"presentation","gtin":"08470006776636","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA TEVA 0,5 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"TEVA B.V.","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2018-10-08","pack_status":"Autorizado","pack_status_date":"2011-04-13"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ctsWkyh1Mnl3J0uvZR_gw9RoA00ByZoGjxuhn-N2TbFIrT7qvCEZDgeSwde2do2mNmL-3AS2VSadgP-fXYFuzw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006776636","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:680369","market":"ES","level":"presentation","gtin":"08470006803691","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA TARBIS 0,5 MG COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"TARBIS FARMA S.L.","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2014-09-10","pack_status":"Autorizado","pack_status_date":"2011-05-13"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"D7oPRYAbzK4F6ndbqX3lhqXujvANgbeBAGCfjeHzdfH7AT3fOqK07C61zK4hXcb9mNPonHy2IFBJ3mwIsVZOnQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006803691","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:680771","market":"ES","level":"presentation","gtin":"08470006807712","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA KERN PHARMA 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"KERN PHARMA S.L.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-01-20","pack_status":"Anulado","pack_status_date":"2021-01-20"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"MeYLVxo_C-b020B2HnYF5raFGMUEIol_YFxZdjWdJdwy_43c3LlCsORvxWEqbtpTVBdo0AkPA3cqzyonNt1U6Q","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006807712","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:680786","market":"ES","level":"presentation","gtin":"08436577301714","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA PENSA 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"TOWA PHARMACEUTICAL S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2013-03-04","pack_status":"Suspenso","pack_status_date":"2024-12-03"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ZWAwMBsBJ3Rj6uEnvvh32SoNXChoMLH0U2fc8JxV1NDb7lH07zWfoHWpi3kGfEN8jpitnBL1M6cSaD9P3GnFKQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08436577301714","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:683795","market":"ES","level":"presentation","gtin":"08470006837955","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA EDIGEN 0,5 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"ARISTO PHARMA IBERIA S.L.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2020-08-06","pack_status":"Anulado","pack_status_date":"2020-08-06"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"3hHBIGli5mKks3I9w97YBkJbJ8koo2CBiGwsFp1-XVhZ5Gnr8jh6FGOg-UYE7w1pBHX4dfWLEy8pAvf0hjBQfA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006837955","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:694097","market":"ES","level":"presentation","gtin":"08470006940976","national_pack_code":null,"pack_level_published":true,"name":"Enyglid 0,5 mg comprimidos EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"KRKA D.D. NOVO MESTO","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2019-04-22","pack_status":"Autorizado","pack_status_date":"2012-10-25"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"17rmxePXuS2Dvp5l8z96g3NWfBfMsDj4kv76Er4LjfVgnZlLxIgVcfpac_CGhyMInko6_DghaPWex4a6W06SAg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006940976","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:694330","market":"ES","level":"presentation","gtin":"08470006943304","national_pack_code":null,"pack_level_published":true,"name":"Repaglinida Accord 0,5 mg comprimidos EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"ACCORD HEALTHCARE S.L.U.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2026-08-28","pack_status":"Anulado","pack_status_date":"2026-08-28"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"EuLQNydDLIC57sv_3GhCpL8TBV-Lr2X9frBjAZ3xiJbX7HJPysVivs9XJ03U3c5loRowIzUdPPR550qH27akYw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006943304","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:695744","market":"ES","level":"presentation","gtin":"08470006957448","national_pack_code":null,"pack_level_published":true,"name":"Repaglinida Krka 0,5 mg comprimidos EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"KRKA D.D. NOVO MESTO","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2020-07-10","pack_status":"Autorizado","pack_status_date":"2012-12-21"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"GYLNroCgdOIHcVooEN2PHEPbMKEmJN5caWmMyZTyV4-3QUprA2WJiXg4cbYNimxZdDxT9T1HDVblaDrqKXi3HQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006957448","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:696155","market":"ES","level":"presentation","gtin":"08470006961551","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA AUROBINDO 0,5 MG COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS AUROBINDO S.L.U.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-07-08","pack_status":"Anulado","pack_status_date":"2021-07-08"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"jN-pHQSdZb92nOA1405KofSk7MU59R9g88E9tjQyAR-avK3PptVn_ILR7lTj7-yE4HERIkvdttDSxWVwuwj8TA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006961551","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:717702","market":"ES","level":"presentation","gtin":"08470007177029","national_pack_code":null,"pack_level_published":true,"name":"NOVONORM 0,5 mg, COMPRIMIDOS, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"NOVO NORDISK A/S","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-07-14","pack_status":"Autorizado","pack_status_date":"1999-06-01"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"bhn8gLb4c4CtHPnIgRdJ5RzsgjTY3bcEiJzBVMYQ1nHHzFCMhXHrMGSgQWmt_O0mqhl_n4LHi4uDkYSWf607Eg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470007177029","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:724862","market":"ES","level":"presentation","gtin":"08470007248620","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA AUROVITAS 0,5 MG COMPRIMIDOS EFG 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"AUROVITAS SPAIN, S.A.U.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2019-08-28","pack_status":"Autorizado","pack_status_date":"2019-02-20"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"jn3croDuV6VCtXEX_idvbu1dl7fAtBXxmC59rhGsMjBtTJ5YIfEiEiX1KOIgPlj1AQZGtpczyJGf_CeowoDcNg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470007248620","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:821967","market":"ES","level":"presentation","gtin":"08470008219674","national_pack_code":null,"pack_level_published":true,"name":"PRANDIN 0,5 mg, COMPRIMIDOS, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["0,5 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"NOVO NORDISK A/S","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2022-08-05","pack_status":"Autorizado","pack_status_date":"2002-03-25"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"KLM1DaneqcWHNUmgzz8XjdjimQWsuMRqVJ1xBukvaIXsS1KMEfrI7kJGwUutykDY1r30pH341ViW_tL3uHZppg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470008219674","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400922227337","market":"FR","level":"presentation","gtin":"03400922227337","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE ACCORD 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) aluminium de 90 comprimé(s)"],"holder":"ACCORD HEALTHCARE (ESPAGNE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"f8TzOjXzk3mxUgUeMRn3vRtJPRehw0cFphgC6qrWDPUh5PiqZxnXxWDBR6TO_igLS8-f6QFhClk3euiZ7-I9MA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400922227337","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400922227627","market":"FR","level":"presentation","gtin":"03400922227627","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE ACCORD 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) aluminium de 270 comprimé(s)"],"holder":"ACCORD HEALTHCARE (ESPAGNE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"rUq84wO5Tdojj0LoIAT8IyMrdfIenKphQhnmsr37g6F1L_bRmmbQ3KvI9SmFeulEzbxC2QWutTipmJATLv61NA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400922227627","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400926644024","market":"FR","level":"presentation","gtin":"03400926644024","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE KRKA 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)"],"holder":"KRKA (SLOVENIE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"4nJ5L1NZaRUMKf07HhoFjG_cimfABNqi8ACbaxMby8dp-dzHgnRgRpHAXr52Xj8QjCTzc0mufQNcTjKVKkwWuA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400926644024","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400926644192","market":"FR","level":"presentation","gtin":"03400926644192","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE KRKA 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 270 comprimé(s)"],"holder":"KRKA (SLOVENIE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"PhFkREez8VQRWz1P8J3aAI35nHSaTgXlEJ4BzfjqPIJrDoVVUlsLcIjddLaZ66Mze8s78wSsz7a1GfRR83nSuA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400926644192","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400926791483","market":"FR","level":"presentation","gtin":"03400926791483","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE EVOLUGEN 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)"],"holder":"EVOLUPHARM","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"jgpvDzgnqIy3fvaLQakPqs_ny5NIs8td95V1_51t4PPxzvip7FtntcKLffDT7w9-kIJ9vEmfYYUDwTAQ28bULg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400926791483","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400926933265","market":"FR","level":"presentation","gtin":"03400926933265","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE ARROW LAB 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)"],"holder":"ARROW GENERIQUES","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"23BMznqww_9oVzRSDdAyMM0vuy5UMkbVzIdm1qqA_RnQBQE3dsUaj06mlZSVo_-fzks3KPdw-SEevEbC_tHi1A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400926933265","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400930036945","market":"FR","level":"presentation","gtin":"03400930036945","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE ARROW LAB 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) polyamide aluminium PVC-Aluminium de 270 comprimé(s)"],"holder":"ARROW GENERIQUES","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"DJ9bSJALYch_77UJOyhS3WJZJgmD7IN8bg_BLPo-35uQuywSqYZiau52GuQ1DvPChMB5t7NfpzqPFdvl2I6PqQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400930036945","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400930208977","market":"FR","level":"presentation","gtin":"03400930208977","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE VIATRIS 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["flacon(s) polyéthylène haute densité (PEHD) de 90 comprimé(s)"],"holder":"VIATRIS SANTE","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"iyVkSEiBkclXGe3qpHRDIKxRDnOvqCT6W6eMqKtln_nk90U5lgLRTd7a4VVM3VjpFduTZXeuGxPP9djeE9tS0w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400930208977","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400934628245","market":"FR","level":"presentation","gtin":"03400934628245","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE TEVA 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) aluminium de 90 comprimé(s)"],"holder":"TEVA (PAYS-BAS)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"8vtR6OicKaXN004OCDxf7_q9WvNO717g8azB9T3C-zhEC3XHlYdeHP3lW6OfEWPVi6qIxkRijVppyCNLFoGxuQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400934628245","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400934628474","market":"FR","level":"presentation","gtin":"03400934628474","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE TEVA 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) aluminium de 270 comprimé(s)"],"holder":"TEVA (PAYS-BAS)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"wTN69M5GsR-SlTQHHfbOYYyAlOihQja5Wc97a7G4nMYMuFoMiHeoBk2mi_DCRbWfWskX_6LSZW5zq4n3N9Ii0g","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400934628474","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400934840272","market":"FR","level":"presentation","gtin":"03400934840272","national_pack_code":null,"pack_level_published":true,"name":"NOVONORM 0,5 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) aluminium de 90  comprimé(s)"],"holder":"NOVO NORDISK (DANEMARK)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"hZdr_NhazPMJVp1JFO6ZoHWLBMVmy3v2VCXgPo-RlEedrM-HwpuvHrmPluzNvBaF91Ca0twqzJD8m5kAiRUFrw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400934840272","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}}],"total":200,"note":"A link shows how two records are related. It does not say one product can be used in place of another.","receipt":{"v":"1","id":"rco-dosidal:751e106e-b4e4-4251-bcdd-e6cf07b3c63f","seq":6113,"writer":"https://dosidal-api.ai","caller":"public","subject":"pl:presentation:87203","subject_type":"-","market":"-","rule_version":"1.0+1.0+open-read:related_records","cleared_at":"2026-11-16T02:05:05Z","answer_hash":"9b51102a78e703aba3f13a58fda3786a7a63400d130f155216e59c787d7dfd29","prev_hash":"171e08b1434628ac83b94e1f1cbac2e2fc2fc8bf62b0a914d14404df180a5a52","hash":"a38f3fe8c6d7777249bd0c4e4a6e967ce22ba490a9833d96850f263097be32b9","kid":"dosidal-rco-1.98a18493","sig":"4ck-GgCNjjl3iZJOQ3x9lJI1_xQRkG0tNoWuO1oQ1NtRsOeFQbbqFXB0fjRUpk1wNOh-Wy-jIe8FoHvtzUw7iA"},"scope":"Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.","notice":"Artificial intelligence makes mistakes. Read the regulator.","region":"wus2"}